Global Emergency Contraceptive Pills Market to Reach US$ 814.3 Million by 2032, Propelled by the Development of Effective and Convenient Emergency Contraceptive Pills

September 29, 2023 | Healthcare

The latest report by IMARC Group, titled “Emergency Contraceptive Pills Market Report by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2024-2032,” finds that the global emergency contraceptive pills market size reached US$ 585.9 Million in 2023. Emergency contraceptive pills, or morning-after pills, are a form of birth control used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. These pills contain hormones, typically levonorgestrel or ulipristal acetate, that work by inhibiting or delaying ovulation, fertilization, or implantation of the fertilized egg into the uterus lining. For instance, one common type of emergency contraceptive pill is the levonorgestrel-based pill, available over-the-counter in many countries. It should be taken after unprotected intercourse, ideally within 72 hours, although its effectiveness decreases with time. Another option is ulipristal acetate, available with a prescription and effective up to 120 hours after unprotected sex. They are meant for occasional use when other forms of contraception fail or are not used. Additionally, emergency contraceptive pills are generally safe and have side effects such as nausea, fatigue, or changes in menstrual cycles.

Global Emergency Contraceptive Pills Market Trends:

The market is primarily driven by the significant increase in awareness and education regarding emergency contraception. In addition, public health campaigns, educational programs, and easy access to information are essential in informing individuals about the availability and proper usage of emergency contraceptive pills, thus influencing market growth. Moreover, several advances in pharmaceutical research led to the development of more effective and convenient emergency contraceptive pills, which increased consumer confidence in the products and their reliability, representing another major growth-inducing factor. Besides this, the easy availability of emergency contraceptive pills over the counter and through healthcare providers removed many barriers that previously hindered individuals from obtaining timely emergency contraception, which is accelerating the market growth. Along with this, the changing societal attitudes toward emergency contraception reduced the stigma associated with its use, allowing more individuals to discuss and seek these products, propelling the market growth. Apart from this, the implementation of several regulatory changes in some countries made it easier to access emergency contraception without a prescription, thus augmenting the market growth. Furthermore, the changing demographics, such as delayed family planning and a focus on career development, are escalating the demand for emergency contraception among women of reproductive age, thus creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 814.3 Million by 2032, exhibiting a CAGR of 3.5% during the forecast period (2024-2032).

Market Summary:

Based on the type, the market has been categorized into combination pills, progesterone pills, and others. Presently, combination pills represent the leading segment.
On the basis of the distribution channel, the market has been divided into retail stores, online stores, and others. Currently, retail stores hold the leading position in the market.
Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. Among these, North America exhibits a clear dominance in the market.
The competitive landscape of the industry has also been examined in the report, with some of the key players being Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., and Syzygy Healthcare Solutions LLC.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Million
Types Covered	Combination Pills, Progesterone Pills, Others
Distribution Channels Covered	Retail Stores, Online Stores, Others
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Emergency Contraceptive Pills Market to Reach US$ 814.3 Million by 2032, Propelled by the Development of Effective and Convenient Emergency Contraceptive Pills

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.